## Sources

1. [Dupilumab Emerges as an Effective Antibody Therapy for Eosinophilic Esophagitis](https://www.annualreviews.org/content/journals/10.1146/annurev-med-042325-045433?TRACK=RSS)
2. [The Role of MicroRNAs in Viral and Bacterial Infections](https://www.annualreviews.org/content/journals/10.1146/annurev-pathmechdis-042424-114814?TRACK=RSS)
3. [Cross-Organ Mitochondrial Communication in Stress and Disease](https://www.annualreviews.org/content/journals/10.1146/annurev-pharmtox-062124-024150?TRACK=RSS)
4. [Erratum: Health Risks and Benefits of Fluoride Exposure During Pregnancy and Infancy](https://www.annualreviews.org/content/journals/10.1146/annurev-pu-46-043026-200001?TRACK=RSS)

---

### **Cross-Organ Mitochondrial Communication in Stress and Disease**
**Authors:** Koning Shen, Jenni Durieux, and Andrew Dillin [1]

*   **Main Arguments:** Mitochondria have evolved beyond their traditional role as the "powerhouse of the cell" to become **central signaling hubs** that communicate with other organelles and distant organs to maintain organismal homeostasis [2, 3]. This communication is facilitated by signaling molecules known as **mitokines**, which include metabolites, lipids, proteins, and even entire mitochondrial organelles [2, 4].
*   **Key Takeaways:**
    *   Cross-organ mitochondrial signaling is essential for regulating **metabolism, immune responses, stress adaptation, and longevity** [2, 5].
    *   Dysfunction in these communication pathways is often linked to age-related diseases and metabolic disorders [2, 6].
    *   Understanding these molecular triggers and signaling mechanisms offers a pathway to developing **novel therapeutics** for diseases associated with mitochondrial dysfunction [2].
*   **Important Details:**
    *   The review examines these pathways across various models, including invertebrates, mammals, and humans [2].
    *   Key stress responses discussed include the **mitochondrial unfolded protein response (UPRmt)** and the **integrated stress response (ISR)**, which relay mitochondrial status to the nucleus and other cells [4, 5].
    *   Specific mitokines, such as **FGF21 and GDF15**, are highlighted for their roles in systemic metabolic adaptation [6, 7].

### **Dupilumab Emerges as an Effective Antibody Therapy for Eosinophilic Esophagitis**
**Authors:** Shifali Arora and Evan S. Dellon [8]

*   **Main Arguments:** Eosinophilic esophagitis (EoE) is a chronic allergic condition driven by a **Type 2 immune response** to allergens, leading to esophageal inflammation and impaired epithelial function [9]. **Dupilumab**, a human monoclonal antibody, has emerged as a breakthrough therapy by targeting the interleukin-4 receptor-alpha (IL-4Rα) [9].
*   **Key Takeaways:**
    *   Dupilumab effectively blocks **IL-4 and IL-13 signaling**, which are the primary drivers of EoE pathogenesis [9].
    *   Clinical trial and real-world data demonstrate that dupilumab reduces **esophageal inflammation**, improves patient symptoms, and helps prevent complications like strictures [9].
    *   This therapy represents a significant shift from traditional treatments such as proton pump inhibitors, topical corticosteroids, and elimination diets [9].
*   **Important Details:**
    *   The article provides a comprehensive review of clinical data across different age groups [9].
    *   It situates dupilumab within an **evolving treatment paradigm**, offering guidance on its role alongside traditional anti-inflammatory methods and esophageal dilation [9].

### **Erratum: Health Risks and Benefits of Fluoride Exposure During Pregnancy and Infancy**
**Authors:** Christine Till, Philippe Grandjean, E. Angeles Martinez-Mier, Howard Hu, and Bruce Lanphear [10]

*   **Main Arguments:** This source is an **erratum (correction)** for a previously published article titled "Health Risks and Benefits of Fluoride Exposure During Pregnancy and Infancy" in the *Annual Review of Public Health* [11].
*   **Key Takeaways:**
    *   The source serves to **correct specific data or text** in the original 2025 publication [11].
    *   While the snippet does not provide the specific details of the correction, it indicates that the original article remains a central reference for the public health discussion on **prenatal and infant fluoride exposure** [11].
*   **Important Details:**
    *   The original article (Volume 46, pages 253–274) explored both the **risks and benefits** of fluoride during critical developmental windows [11].

### **The Role of MicroRNAs in Viral and Bacterial Infections**
**Authors:** Laura Groeger, Eckart Meese, and Andreas Keller [12]

*   **Main Arguments:** MicroRNAs (miRNAs) are fundamental regulators of **gene expression and cellular homeostasis** [13]. While their role in cancer is well-documented, they are also critical mediators in the host's response to **viral and bacterial pathogens** [13].
*   **Key Takeaways:**
    *   Host miRNAs can either **inhibit or facilitate** pathogen replication; for example, specific miRNAs like **miR-21, miR-146a, and miR-155** are central players in the inflammatory and immune response to infection [13, 14].
    *   The interaction is complex, involving both the **host's miRNA response** and **pathogen-derived small regulatory RNAs** that attempt to subvert host defenses [13, 15].
    *   Future research must prioritize functional studies and the investigation of **cross-kingdom RNA exchange** to better understand infection mechanisms [13].
*   **Important Details:**
    *   The discovery of miRNAs was recognized with the **2024 Nobel Prize**, underscoring their biological importance [13].
    *   The source details specific interactions, such as how **miR-122** is sequestered by the Hepatitis C virus to promote its own stability [16].
    *   In bacterial infections like *Mycobacterium tuberculosis*, host miRNAs are modulated to regulate processes like **autophagy and apoptosis** to control or facilitate bacterial survival [15, 17].